Citius Pharmaceuticals, Inc. (CTXR) at a glance

Citius Pharmaceuticals, Inc. (CTXR) is a micro-cap Healthcare company. It trades at $0.55, with a 0% profit margin and revenue decline of 57.7%. It does not pay a dividend. Vestovix scores it 40/100 overall. Its strongest dimension is Safety (64/100) and its weakest is Growth (12/100). Its volatility is roughly in line with the market.

Price

$0.55

Market cap

$14.8M

P/E ratio

n/a

Dividend yield

None

Beta

0.98

52-week range

$0.48 to $2.48